Drug Product
Clinical Trial Supply & Logistics
Company Overview
About
Ivers‑Lee Group is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:Switzerland
Founded:1994
Employees:728
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Europe
Manufacturing Facilities
1 site worldwide
Ivers-Lee SA
Kirchbergstrasse 160, Burgdorf, BE, 3400
Site Capabilities
2 capabilitiesPACK
REPACK
Regulatory Approvals
Drug Approval QVEW92
EMA · #APR-DZL092QY · 2021-02-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-R58KEHRN
Issued: 2020-05-02
Expires: 2025-06-17
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-6D1F4PPG
Issued: 2020-11-23
Expires: 2025-04-09
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-162GSKL6
Issued: 2020-02-22
Expires: 2025-01-01
WHO GMP
World Health Organization
Cert #: CERT-JXKZHOUT
Issued: 2020-11-15
Expires: 2025-07-17
Loading CDMO intelligence...
Key facts about Ivers‑Lee Group
- Ivers‑Lee Group is headquartered in Switzerland.
- Ivers‑Lee Group was founded in 1994.
- Ivers‑Lee Group has 728 employees.
- Ivers‑Lee Group has one manufacturing site listed on CDMO Hub, in Burgdorf, Switzerland.
- Ivers‑Lee Group's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Ivers‑Lee Group
Directory pages this company appears in, each with the full list of matching manufacturers.